Latest return on equity
Neurocrine Biosciences Return on equity
Neurocrine Biosciences (NBIX) return on equity with its verified observation da…
Direct answer
Neurocrine Biosciences's return on equity is 22.09%.
The verified market snapshot reports 22.09%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 2, 2026.
Get free Neurocrine Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 22.09%
Explore related company data
View Neurocrine Biosciences's market capitalizationView Neurocrine Biosciences's p/e ratioView Neurocrine Biosciences's price-to-book ratioView Neurocrine Biosciences's 52-week price rangeView Neurocrine Biosciences's revenue growthView Neurocrine Biosciences's profit marginView Neurocrine Biosciences's debt-to-equity ratioView all Neurocrine Biosciences key metricsReturn to Neurocrine Biosciences profile